Protective Effect of Lipo-PGE1 on Myocardial Injury Following Percutaneous Coronary Intervention
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
we hypothesized that periprocedural treatment with intravenous lipo-PGE1 may reduce
myocardial injury and improve clinical outcomes in patients undergoing PCI.